Live Breaking News & Updates on Stryker Corporation Entellus Medical Inc

Stay updated with breaking news from Stryker corporation entellus medical inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Growth Opportunities in the United States Drug Eluting Sinus Stent Market to 2025, Featuring Intersect ENT, Inc., Johnson & Johnson, Medtronic plc and Stryker Corporation


Share this article
Share this article
ResearchAndMarkets.com s offering.
The US drug eluting sinus stent (DESS) market has increased significantly during the years 2018-2020, and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The drug eluting sinus stent (DESS) market is expected to increase due to surging healthcare expenditure, increasing prevalence of sinus related disorders, growing treatment in physician s office, limitations of FESS, favorable government initiatives for promoting the use of sinus stents, etc. Yet the market faces some challenges such as economic slowdown, high cost involved, use of oral steroids and packing material. ....

Laura Wood , Intersect Ent Inc , Office Hours Call , Company Profiles , E St Office Hours Call , Johnson Acclarent Inc , Stryker Corporation Entellus Medical Inc , Treatment In Physician Office , Eluting Sinus Stent , Endoscopic Sinus Surgery , Balloon Sinus Dilation , Stryker Corporation , Entellus Medical , Topics Covered , Surgery Market , Sinus Dilation , Sinus Related , Government Initiatives , Oral Steroids , Innovative Techniques , Chronic Sinusitis , Minimally Invasive , Market Players , Senior Manager , Free Call , Hours Call ,